Author Correction: FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Phase 1 study of the FcRH5×CD3 bispecific antibody cevostamab for relapsed or refractory multiple myeloma

  • By

  • Adam D. Cohen

  • Joshua Richter

  • Suzanne Trudel

  • Alexander Lesokhin

  • Jacob P. Laubach

  • Sheeba K. Thomas

  • Simon J. Harrison

  • Luciano J. Costa

  • Andrew Spencer

  • Rafael Fonseca

  • Peter A. Forsberg

  • Jesus G. Berdeja

  • Rayan Kaedbey

  • Nizar J. Bahlis

  • Paula Rodriguez-Otero

  • Maria-Victoria Mateos

  • Tulika Tyagi

  • Divya Samineni

  • Wenyu Liu

  • Rin Nakamura

  • Voleak Choeurng

  • Chihunt Wong

  • James Cooper

  • Amrita Krishnan

  • October 20, 2026

Share

Objective:

Report a correction to the labeling in Extended Data Fig. 3b.

Approach:
  • Correction: In both panels, the left x-axis label was corrected from “No 1q gain or amp” to “1q normal”.
  • Publication: The correction was published online on 22 July 2026 and implemented in the HTML and PDF versions.
Key Findings:
  • The correction concerns the left x-axis label in both panels of Extended Data Fig. 3b.
Interpretation:

The correction changes the left x-axis label in both panels of Extended Data Fig. 3b from “No 1q gain or amp” to “1q normal”.

Limitations:
  • The provided context does not include the original study’s methods or results.
Sources:

Original Source(s)

Author Correction: FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial

  • by Adam D. Cohen, Joshua Richter, Suzanne Trudel, Alexander Lesokhin, Jacob P. Laubach, Sheeba K. Thomas, Simon J. Harrison, Luciano J. Costa, Andrew Spencer, Rafael Fonseca, Peter A. Forsberg, Jesus G. Berdeja, Rayan Kaedbey, Nizar J. Bahlis, Paula Rodriguez-Otero, Maria-Victoria Mateos, Tulika Tyagi, Divya Samineni, Wenyu Liu, Rin Nakamura, Voleak Choeurng, Chihunt Wong, James Cooper, Amrita Krishnan

  • October 20, 2026

Related Content

Impact of AI-Assisted Endoscopy on Secondary Review and Referral Decisions in Gastric Cancer Screening: A Multicenter Real-World Study

Error in Supplement 2

  • October 19, 2026

Expanding surgical options for liver cancer and liver metastases

Advances in minimally invasive surgery and liver-directed therapies at UCI Health offer new treatment for complex liver malignancies.

  • October 14, 2026

  • 2 min